BRIEF-Moderna Announces Positive Prelim Immunogenicity Data For 2025-2026 Formula Of mNEXSPIKE

Reuters
Sep 23
BRIEF-<a href="https://laohu8.com/S/MRNA">Moderna</a> Announces Positive Prelim Immunogenicity Data For 2025-2026 Formula Of mNEXSPIKE

Sept 23 (Reuters) - Moderna Inc MRNA.O:

  • MODERNA: POSITIVE PRELIM IMMUNOGENICITY DATA FOR 2025-2026 FORMULA OF MNEXSPIKE, WHICH TARGETS LP.8.1 VARIANT OF SARS-COV-2

  • MODERNA: PRELIM ANALYSIS SHOWED 2025-2026 FORMULA OF MNEXSPIKE GENERATED >16-FOLD INCREASE IN LP.8.1-NEUTRALIZING ANTIBODIES ACROSS AGE GROUPS

  • MODERNA: SAFETY PROFILE OF VACCINE CONSISTENT WITH PREVIOUS STUDIES

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10